Onemednet CORP (ONMD) Institutional Investor Snapshot (22 Funds, Q2 2026)

ONMD ranks #8180 out of 37503 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

22 institutions disclose a position in ONMD, but none treat it as a major bet — even Savant Capital, LLC, its most concentrated holder, allocates just 0.0% of its own portfolio to it.

UBS Group AG has trimmed its ONMD position for two straight quarters, cutting it by $113.6K while still holding $11.5K.

ONMD is down 0.9% today, but institutions show net buying of $5.4M this quarter — a divergence between today's price move and the underlying institutional flow.

ONMD reported a net loss of $8.5M over the trailing twelve months.

• Not yet profitable — net loss of $8.5M over the trailing twelve months
• Revenue grew 216.5% year over year
• Net income declined year over year, from -$3.4M to -$8.5M
• Operating cash flow was negative, using $7.5M in cash
• Current ratio of 0.43x — below the conventional 1.5x liquidity buffer
• Liabilities run 2558.00x equity — a highly leveraged balance sheet worth noting